Status: Recruiting
Evaluation of Platelet-Rich Plasma (PRP) Treatment in Tendinopathies
This multicenter, prospective, observational study, based on real-world evidence (RWE), aims to evaluate the efficacy and safety of Platelet-Rich Plasma (PRP) treatment across four types of tendinopathies: patellar, Achilles, epicondylar, and plantar fasciosis. Data collection and analysis will be conducted using the BioSmartData® platform, including hematology analyzers for PRP characterization, clinical variables, treatment protocols, and longitudinal assessment of therapeutic response.
Participants needed: 2,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: ReSport ClinicUpdated: Apr 30, 2026Locations: 5
Eligibility criteria
Clinical and/or ultrasound diagnosis of chronic tendinopathy (duration >6 weeks) [+3]
Surgical treatment of the affected tendon within the previous 6 months [+5]